Dataset
Downregulation of ubiquitin-specific protease 15 (USP15) does not provide therapeutic benefit in experimental mesial temporal lobe epilepsy
- 1Experimental Epilepsy Research, Department of Neurosurgery, Medical Center - University of Freiburg, Faculty of Medicine, 79106, Freiburg, Germany
- 2Early Solutions, UCB Biopharma SRL, Chemin du Foriest, 1420 Braine l’Alleud, Belgium
- 3Early Development Statistics, UCB Celltech, 208 Bath Road, Slough, Berkshire, SL1 3WE, United Kingdom
- 4Institute for Neuropathology, Medical Center - University of Freiburg Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
DOI: 10.12751/g-node.3nhe4v BROWSE REPOSITORY BROWSE ARCHIVE DOWNLOAD ARCHIVE (ZIP 55 GiB)
Published 16 Oct. 2023 | License Creative Commons CC0 1.0 Public Domain Dedication
Description
Here we provide the EEG and immunocytochemistry datasets for the study published as Häussler et al., 2023, Molecular Neurobiology, in press. Data is given for individual knockout mice or wildtype littermates.
Keywords
| Ubiquitin-specific proteases | TGF-beta | INF-alpha/beta | NRF2 | Kainate |References
- Ute Häussler, João Neres, Catherine Vandenplas et al. Downregulation of ubiquitin-specific protease 15 (USP15) does not provide therapeutic benefit in experimental mesial temporal lobe epilepsy. Molecular Neurobiology, in press. https://doi.org/10.1007/s12035-023-03692-2
- Ute Häussler, João Neres, Catherine Vandenplas et al. Downregulation of ubiquitin-specific protease 15 (USP15) does not provide therapeutic benefit in experimental mesial temporal lobe epilepsy, 13 March 2023, PREPRINT (Version 1) available at Research Square. https://doi.org/10.21203/rs.3.rs-2625841/v1